Heritable RNA interference (RNAi), triggered from stably expressed transgenes with an inverted repeat (IR) con®guration, is an important tool for reverse genetic studies. Here we report on the development of stable RNAi in Anopheles stephensi mosquitoes, the major vector of human malaria in Asia. Transgenic mosquitoes stably expressing a RNAi transgene, designed to produce intron-spliced double-stranded RNA (dsRNA) targeting the green uorescent protein EGFP gene, were crossed to an EGFP-expressing target line. EGFP expression was dramatically reduced at both the protein and RNA levels. The levels of gene silencing depended upon the RNAi gene copy number and its site of integration. These results demonstrate that speci®c RNAi-mediated knockdown of gene function can be achieved with high ef®ciency in Anopheles. This will be invaluable to systematically unravel the function of Anopheles genes determining the vectorial capacity of the malaria parasite.
INTRODUCTION
Stable and heritable RNA interference (RNAi), a form of posttranscriptional gene silencing that results in the sequencespeci®c degradation of mRNA by homologous dsRNA molecules (1, 2) , has been utilized in numerous organisms including Caenorhabditis elegans (3), trypanosomes (4, 5) , Drosophila (6±8), plants (9) and, recently, by expressing short-interfering RNAs in mammalian cells (10) to investigate the function of target genes. Because of its¯exibility, RNAi technology has become a powerful tool for reverse genetic studies in organisms where generating loss-of-function phenotypes by the direct manipulation of target genes has proven dif®cult or impossible. In Anopheles mosquitoes, the vectors of human malaria, genetic transformation is routinely achieved through a transposon-mediated integration process which occurs at random locations in the genome (11, 12) , thus preventing the targeted disruption or manipulation of any gene of choice. As an alternative to gene targeting by conventional methods, RNAi in Anopheles has been employed in the form of injection of in vitro synthesized dsRNA molecules into adult Anopheles gambiae mosquitoes (13) . However, experimental evidence indicates that the silencing effects of injected dsRNA are generally limited in time and space (14, 15) . The development of a heritable and robust RNAi technology for anopheline mosquitoes would provide the opportunity to exploit the information generated by the recent completion of the A.gambiae genome sequencing project (16) . The application of this RNAi technology for reverse genetic screens could be used to assess the role of putative genes involved in interactions with Plasmodium parasites, as well as expanding the knowledge of important biological processes, such as embryogenesis, sex determination and behavior.
To validate heritable RNAi technology in Anopheles, we targeted an EGFP gene integrated in the genome of transgenic Anopheles stephensi mosquitoes (17) . We anticipated that this approach would facilitate the assessment of the ef®ciency of the technology without the bias introduced by the loss of function of endogenous genes. For this purpose A.stephensi lines were developed using a red¯uorescent protein DsRedmarked transposon, which contained an RNAi gene (18) designed to encode an intron-spliced dsRNA targeting the green¯uorescent protein EGFP gene. Transgenic lines were crossed to EGFP-expressing mosquitoes, and the progeny of the crosses analyzed for EGFP expression at both the protein and the RNA levels. Various degrees of inhibition were observed, ranging from marginal to high level silencing. The reduction in EGFP expression was dependent upon the site of integration of the inverted repeat (IR) transgene and its copy number.
MATERIALS AND METHODS

Plasmid construction
Plasmid pIR-EGFP was developed as described previously (19) . Brie¯y, EGFP IR were produced by duplicating, in the opposite direction, the EGFP gene (Clontech) by directionally inserting a 465 bp (from position 219 to 683) PCR product into the plasmid pCR2.1v (Invitrogen). To link the two arms of the inverted repeat, a 67 bp PCR product corresponding to intron 1 from the A.gambiae lysozyme gene (GenBank accession no. U28809) was ampli®ed from A.gambiae genomic DNA and inserted between the EGFP-IR (Fig. 1a) , as previously described (19) . This IR-EGFP cassette was then inserted between the Actin5C promoter and Hsp70 terminator elements from Drosophila melanogaster and cloned as a NotI cassette *To whom correspondence should be addressed. Tel: +44 20 75945412; Fax: +44 20 75945439; Email: f.catteruccia@imperial.ac.uk into a minos-based plasmid that contained the DsRed marker gene, also cloned under the control of the Actin5C promoter (Fig. 1a) .
Development of transgenic RNAi lines
Wild-type A.stephensi embryos (strain sd 500) were injected, essentially as described previously (11) , with a mixture of helper plasmid pHSS6hsILMi20 (100 mg/ml) (20) and pIR-EGFP (400 mg/ml) (19) . Homozygous lines were developed as described previously (11) .
Southern blot analyses of transgenic lines
Genomic DNA from transformed adult mosquitoes (G 3 and G 9 generations) was digested with either EcoRI and NotI or HincII restriction endonucleases. Digested genomic DNA (~4 mg/lane) was separated on a 0.8% (w/v) agarose gel and transferred onto a nylon membrane. Membranes were hybridized overnight at 65°C with the following 32 P-labeled probes. Probe M: a PCR product encompassing the terminal inverted repeats of the left and right minos arms, as described previously (11) . Probe EGFP-S: a 0.65 kb PCR product complementary to the sense arm of IR-EGFP, ampli®ed using the primer combination pEGFP-S 465 for (5¢-CCCGGA-TCCCCGCTACCCCGACCA-3¢) and pEGFP-S 465 com (5¢-CCCGATATCGCGGCGGTCACGAAC-3¢). Probe HST: a 0.9 kb PCR product corresponding to the D.melanogaster Hsp70T gene, ampli®ed using the primer combination pHSTfor (5¢-CCCCTCTAGATGTACGAACACGCATTT-ATC-3¢) and pHSTcom (5¢-CCCCGCGGCCGCCACACG-GGCGAGCGACCA-3¢). Between different hybridizations, the ®lter was washed with a 1.5 M NaCl, 0.5 N NaOH solution for 10 min to remove the hybridized probe.
Quanti®cation of EGFP protein expression
Digital images of larvae were captured on a Nikon inverted microscope using an attached Nikon DXM1200 digital camera. Fluorescent gene expression was quanti®ed using the Lucia G image processing and analysis software (version 4.61; Nikon UK) as previously described (21) . EGFP expression was calculated for 20 individual F 1 and F 1 Backcross larvae per experiment, 5 days post-hatching. For statistical analyses, unpaired t-tests were performed; the null hypothesis was rejected at P b 0.05. c 2 tests were performed to demonstrate that the observed level of gene expression in the F 1 Backcross crosses did not statistically deviate from the expected (50%) level of EGFP expression in F 1 progeny when a second copy of the RNAi gene was supplied.
RNA extraction and cDNA synthesis
Total RNA was extracted from 10 fourth instar larvae from the F 1 Backcross crosses. Brie¯y, larvae were homogenized in RNA extraction buffer (1% SDS, 1 mg/ml proteinase K, 100 mM EDTA, 125 mM NaCl, 50 mM Tris±HCl, pH 7.6) and incubated at 50°C for 1 h. Homogenates were phenol± chloroform extracted and RNA selectively precipitated from solution by three successive 8 M lithium chloride precipitations. Samples were treated with DNase RQ1 (0.2 U/mg total RNA) (Promega) and used for cDNA synthesis. An aliquot of 1 mg of DNase-treated total RNA was reverse transcribed using oligo(dT) 12±18 and SuperScriptÔ II (Invitrogen) according to the manufacturer's instructions.
Quantitative real-time PCR
EGFP mRNA quanti®cation was performed on an ABI 7700 PRISMÔ Sequence Detector (Applied Biosystems). EGFP MGB-TaqManÔ primers and probes (ABI) were designed using Primer Express software (ABI) in the 5¢ coding sequence upstream of the IR-EGFP, to amplify a 69 bp PCR product (nucleotides 66±133). The sequences of the primers were as follows: EGFP-F, 5¢-CGTAAACGGCCACAAGTT-CAG-3¢; EGFP-R, 5¢-GGGTCAGCTTGCCGTAGGT-3¢. The probe (EGFP-P, 5¢-CCCTCGCCCTCGC-3¢, nucleotides 95± 108) was labeled with the reporter dye 6-carboxy¯uorescein (6¢-FAM) at the 5¢ end and with the quencher dye 6-carboxytetramethylrodamine (TAMRA) at the 3¢ end. EGFP expression values were normalized to expression levels of the A.stephensi ribosomal S7 gene. Primers and a FAM/TAMRA probe were designed from the orthologous A.gambiae S7 gene (22) to amplify an 84 bp product: S7-F, 5¢-GGTGCACCTG-GATAAGAACCA-3¢; S7-R, 5¢-CGGCCAGTCAGCTTCTT-GTAC-3¢; S7-P, 5¢-AGACCACCATCGAACACAAAGT-TGACACGT-3¢. cDNA prepared from F 1 progeny of the control cross between line V B and wild-type mosquitoes was used to develop standard curves for each gene and to determine the relative EGFP expression in the experimental crosses. Measurements of gene expression were taken in quadruplicate from two separate experiments and their mean used for further analyses. In each run a negative control (wildtype mosquito cDNA) and an RNA sample without a reverse transcriptase step (to determine genomic DNA contamination) was included.
RESULTS
Development of transgenic RNAi lines
To assess the feasibility of targeted gene silencing through the in vivo expression of dsRNA from stably integrated RNAi genes in Anopheles mosquitoes, we employed EGFP as the target gene (17) . We reasoned this¯uorescent marker gene would provide a simple and impartial model for assessing the ef®cacy of gene silencing by allowing analysis at the protein level both visually and quantitatively using image processing software. Transgenic mosquito lines were engineered to stably express an EGFP-targeting RNAi gene. A total of 610 A.stephensi embryos were injected with transformation construct pIR-EGFP (19) , which contained the EGFP RNAi gene under the transcriptional control of the Actin5C promoter from D.melanogaster and a DsRed selectable marker expression unit (Fig. 1a) . The progeny of the 60 surviving adults showed the presence of 17¯uorescent phenotypes derived from a minimum of four G 0 individuals. Southern blot analyses on HincII-digested genomic DNA (G 3 generation) were performed and hybridized with probe M, spanning the left and right inverted repeats of minos (Fig. 1b) . A total of 13 individual transgenic lines were detected (Fig. 1b) , representing a minimum integration frequency of 6.7%. In these lines, two bands of variable size hybridized with probe M in each case (Fig. 1b) , suggesting the occurrence of a single minosmediated transformation rather than random integration of the whole plasmid. Six independent lines (lines eIR-A 1 , eIR-A 2 , eIR-A 3 , eIR-B 1 , eIR-C 2 and eIR-19 1 ) were selected for further studies. To determine the structural stability of the IR-EGFP integrated transgene, EcoRI/NotI-digested genomic DNA was also hybridized with probe EGFP-S, corresponding to the sense arm of IR-EGFP. On the basis of the speci®c restriction pattern of pIR-EGFP (Fig. 1a) , a single internal band of 4.5 kb was expected. Surprisingly, no band was detected in two (lines eIR-A 1 and eIR-C 2 ) of the six transgenic lines (Fig. 1c, upper  panel) , indicating a deletion within the IR-EGFP cassette. Hybridization with probe HST, spanning the terminator sequence present in both the DsRed and IR-EGFP cassettes, gave two bands of the expected sizes in four out of the six lines. However, only one band, corresponding to the Hsp70T element of the DsRed expression unit, was obtained in lines eIR-A 1 and eIR-C 2 (Fig. 1c, lower panel) , demonstrating that the deletion involved the entire RNAi gene cassette. Southern blot analysis was also performed on the same six transgenic lines at generation G 9 using the same three probes. Hybridizations identical to those obtained in generation G 3 were observed (data not shown).
Analysis of EGFP silencing
To estimate the silencing ef®ciency of the integrated RNAi gene, homozygous male mosquitoes from the six selected transgenic lines (eIR-A 1 , eIR-A 2 , eIR-A 3 , eIR-B 1 , eIR-C 2 and eIR-19 1 ) were crossed to virgin females of transgenic line V B , homozygous for EGFP (11). These six RNAi lines were selected as they exhibited various phenotypes in terms of the spatial distribution of the marker and intensity of its¯uores-cence and carried a single copy insertion of the transgene. Genetic crosses had proven that these IR-EGFP lines contained the RNAi gene integrated into a chromosome different from that carrying the EGFP gene of target line V B (data not shown), to ensure two copies of the RNAi transgene and one copy of the EGFP target gene could be obtained in backcross experiments. Quantitative analysis of EGFP protein levels in the F 1 progeny of the crosses, heterozygous for both the RNAi gene and EGFP target gene, was performed using image processing and analysis software (21) . Among the four lines that Southern blot analysis had shown to contain the RNAi gene, eIR-B 1 and eIR-19 1 mediated a signi®cant inhibition of gene expression, reducing EGFP levels by 43 and 37%, respectively, as compared to heterozygous line V B larvae (Fig. 2a) . As expected, no inhibition was observed in lines eIR-A 1 and eIR-C 2 , where the RNAi gene had been deleted. Heterozygous adult females from each cross were then backcrossed to males homozygous for the RNAi gene, and individuals possessing two copies of the RNAi gene and one copy of the EGFP target gene were analyzed for EGFP levels (F 1 Backcross ). Lines eIR-B 1 and eIR-19 1 consistently mediated a highly signi®cant reduction in EGFP expression, averaging 73 and 65%, respectively (Fig. 2a) . Remarkably, EGFP levels in these crosses were approximately halved with respect to those obtained in the F 1 cross (c 2 = 0.7). EGFP expression in lines eIR-A 1 and eIR-C 2 , which did not contain the RNAi unit, was again unaffected. Finally, lines eIR-A 2 and eIR-A 3 did not show a signi®cant reduction in EGFP levels in either the F 1 or F 1 Backcross progeny (Fig. 2a) . Interestingly, in these lines the spatial pattern of DsRed expression did not colocalize perfectly with EGFP expression from line V B (Fig. 3) , thus suggesting that the RNAi gene and its target were not transcribed in the same cells. As previously demonstrated (19) , DsRed expression did not affect EGFP levels, as determined by EGFP intensity in the crosses between line V B and lines MinRED1, eIR-A 1 and eIR-C 2 , which contained the DsRed marker cassette but not the RNAi unit.
To determine the levels of EGFP transcripts, a random sample of 10 F 1 Backcross larvae from each cross was used for RNA extraction and cDNA synthesis. The abundance of EGFP mRNA in each cross was determined by real-time PCR, using a probe and primers to amplify a 69 bp region of the EGFP gene not common to the IR-EGFP sequence. Results were normalized to the A.stephensi ribosomal S7 gene (22) and relative EGFP mRNA levels calculated.
In accordance with the analysis of EGFP protein expression, F 1 Backcross larvae derived from crosses involving lines eIR-B 1 and eIR-19 1 exhibited a signi®cant reduction in EGFP transcripts, averaging 58 and 78%, respectively, as compared to heterozygous line V B control larvae (Fig. 2b) . Line eIR-A 2 also mediated a signi®cant reduction in EGFP mRNA levels (34%). In agreement with the protein data, no signi®cant reduction in EGFP transcripts was observed in crosses with lines eIR-A 3 , eIR-A 1 and eIR-C 2 .
DISCUSSION
In order to investigate the feasibility of establishing a stable and heritable RNAi technology in mosquitoes, EGFP from a transgenic A.stephensi line was selected as the target gene. It was reasoned that EGFP could provide an impartial model to determine the feasibility of stable RNAi in Anopheles. The rationale for this was based on the consideration that silencing of the EGFP transgene would produce a neutral phenotype for the mosquito, avoiding the risks of selection bias associated with high silencing activity against important or vital endogenous genes.
The RNAi gene was designed to produce intron-spliced dsRNA, which our previous studies had demonstrated could mediate transient RNAi with high ef®ciency against EGFP (19) . In that study, EGFP silencing achieved in transient transfection experiments of Anopheles cells and larvae averaged 93 and 69%, respectively. When stably expressed, this RNAi gene suppressed EGFP expression by up to 73% at the protein level and 78% at the RNA level. The introncontaining RNAi gene was utilized here on the assumption that it would be less susceptible to the genomic rearrangements reported to occur in constructs containing uninterrupted repeats (23) . Our analysis, however, revealed the complete absence of the RNAi unit in two of the transgenic lines studied. This ®nding could be explained by recombination events that took place either within the plasmid itself or genomically. Recombination may have been triggered by the presence of the symmetrically parallel RNAi and DsRed transcription units (Fig. 1a) , sharing identical promoter and terminator sequences, rather than as a direct consequence of the presence of the IR in the RNAi gene itself. Importantly, the integrated constructs showed genomic stability beyond nine generations, which argues for construct instability at the time of injection.
Our data clearly indicate that silencing effects were improved by doubling the RNAi gene copy number, in accordance with similar studies using IR transgenes in Drosophila (7, 8) . Levels of EGFP protein expression were approximately halved when a second copy of the IR transgene was provided in two of the crosses. Furthermore, silencing ef®ciency appeared to be dependent upon the site of integration of the RNAi gene. Silencing was only observed in those lines where the expression pattern of the EGFP target gene and the RNAi gene, as determined by DsRed expression, overlapped. This is in agreement with studies of transgene-mediated RNAi in Drosophila (23, 24) , indicating that RNAi is not systemic and does not spread across mosquito cells. Whether this suggests a lack of dsRNA ampli®cation in Diptera, common to Neurospora (25), plants (26) and C.elegans (27) , is yet to be established, but it may simply re¯ect the postulated inef®ciency of dsRNA formation from transgenes, possibly because nuclear RNAbinding proteins prevent dsRNA annealing (28) .
While it is impossible to extrapolate the results of this study to endogenous mosquito genes, the level of gene silencing achieved here is encouraging despite the fact that we were unable to completely abolish the EGFP phenotype. Since RNAi only knocks down target gene expression, it could offer an advantage in performing functional genomic studies on vital genes and produce a range of useful phenotypes that are missed in classical knockout studies. Because minos reliably creates multiple genetic lines, an array of useful hypomorph phenotypes is likely to be generated for most studies.
The results reported here represent the ®rst example of stable RNAi in Anopheles. This approach can now be applied to study mosquito molecules that have been postulated to function as receptors for malaria parasite development. Furthermore, stable RNAi could greatly contribute to the understanding of important mosquito physiological functions, including chemoreception, locomotion, osmoregulation and homeostasis, taking advantage of the recently published A.gambiae genome sequence (16) .
